We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh‐frozen breast/ovarian tumor versus blood.
- Authors
Schwartz, Mathias; Moncoutier, Virginie; Peytral, Adrien; Le Gall, Jessica; Suybeng, Voreak; Pagès, Mélanie; Masliah‐Planchon, Julien; Trabelsi‐Grati, Olfa; Melaabi, Samia; Callens, Céline; Bièche, Ivan; Delhomelle, Hélène; De Pauw, Antoine; Saule, Claire; Mouret‐Fourme, Emmanuelle; Gauthier‐Villars, Marion; Buecher, Bruno; Colas, Chrystelle; Stoppa‐Lyonnet, Dominique; Golmard, Lisa
- Abstract
In breast or ovarian cancer (BC/OC) patients with evocative personal and/or family history, multigene panel sequencing is performed on blood to diagnose hereditary predispositions. Additionally, BRCA1/BRCA2 testing can be performed on tumor sample for therapeutic purpose. The accuracy of multigene panel tumor analysis on BC/OC to detect predisposing germline pathogenic variants (gPV) has not been precisely assessed. By comparing sequencing data from blood and fresh‐frozen tumor we show that tumor genomic instability causes pitfalls to consider when performing tumor testing to detect gPV. Even if loss of heterozygosity increases germline signal in most cases, somatic copy number variants (CNV) can mask germline CNV and collapse point gPV variant allele frequency (VAF). Moreover, VAF does not allow an accurate distinction between germline and somatic pathogenic variants.
- Subjects
BREAST; OVARIAN tumors; DNA copy number variations; GENE frequency; OVARIAN cancer; GERM cells
- Publication
Clinical Genetics, 2023, Vol 104, Issue 1, p107
- ISSN
0009-9163
- Publication type
Article
- DOI
10.1111/cge.14327